Articles by Joshua N. Liberman, PhD
Reducing Long-Term Cost by Transforming Primary Care: Evidence From Geisinger's Medical Home Model
ByDaniel D. Maeng, PhD,Jove Graham, PhD,Thomas R. Graf, MD,Joshua N. Liberman, PhD,Nicholas B. Dermes, BS,Janet Tomcavage, RN, MSN,Duane E. Davis, MD,Frederick J. Bloom Jr, MD, MMM,Glenn D. Steele Jr, MD, PhD ProvenHealth Navigator, Geisinger's version of advanced patient-centered medical homes, is associated with significant savings in total cost of care over time.
Adherence to Medication Under Mandatory and Voluntary Mail Benefit Designs
ByJoshua N. Liberman, PhD,David S. Hutchins, MHSA, MBA,Will H. Shrank, MD,Julie Slezak, MS,Troyen A. Brennan, JD, MD Pharmacy benefit designs that mandate mail pharmacy use interfere with prescription drug access, particularly for individuals without previous mail pharmacy experience.
Healthcare Information Technology Interventions to Improve Cardiovascular and Diabetes Medication Adherence
ByAlexander S. Misono, BA,Sarah L. Cutrona, MD, MPH,Niteesh K. Choudhry, MD, PhD,Michael A. Fischer, MD, MS,Margaret R. Stedman, PhD,Joshua N. Liberman, PhD,Troyen A. Brennan, MD, JD,Sachin H. Jain, MD, MBA,William H. Shrank, MD, MSHS Despite increasing availability of healthcare information technology, a literature review showed few clinical data on medication adherence interventions using this technology.
Modes of Delivery for Interventions to Improve Cardiovascular Medication Adherence
BySarah L. Cutrona, MD, MPH,Niteesh K. Choudhry, MD, PhD,Michael A. Fischer, MD, MPH,Amber Servi, BA,Joshua N. Liberman, PhD,Troyen A. Brennan, MD, JD,William H. Shrank, MD, MSHS In this review of randomized controlled trials designed to improve adherence to cardiovascular medications, electronic interventions and in-person, pharmacy-based interventions showed the highest success rates.